Antihemophilic factor (recombinant) formulated with sucrose reconstituted with liposome diluent | |
---|---|
Trade Name | Kogenate Fs/Liposomal Diluent |
Orphan Indication | Hemophilia A |
USA Market Approval | USA |
USA Designation Date | 2009-04-29 00:00:00 |
Sponsor | Bayer HealthCare LLC;555 Whiteplains Road;Tarrytown, New York, 10591 |
Related Access Program
Joanne Kurtzberg, MD – Hypoxia Ischemia, Cerebral
Genentech, Inc. – Hemophilia A
GlaxoSmithKline – Systemic Lupus Erythematosus
Vitreous -Retina- Macula Consultants of New York – Retinal Hemangioma
Xiaofan Zhu – Hematopoiesis Maintainance.
Seoul National University Hospital – Chemical Burn
Paolo Caimi, MD – Hematopoietic/Lymphoid Cancer
Zimmer Biomet – Critical Limb Ischemia